HealthCapital Berlin Brandenburg

digitalHealthCapital@DMEA2026

20 – 24 Apr 2026 | Berlin, Germany

PartnershipUpdated on 30 March 2026

Companion digital intervention for metabolic therapies (CGM + nutrition + coaching)

Cofounder & CSO at Clear.bio

Amsterdam, Netherlands

About

Clear.bio is a CE-marked digital intervention for people with Type 2 Diabetes that complements pharmacological treatments by translating real-time CGM data into personalised, actionable lifestyle guidance.

By combining glucose insights with tailored nutrition advice and remote dietitian coaching, Clear.bio supports improved treatment response, stronger patient engagement, and better adherence in daily practice. The intervention is already reimbursed and implemented in primary care in the Netherlands, with strong real-world outcomes.

We collaborate with pharma and medtech partners to develop companion programs around metabolic therapies such as GLP-1, SGLT2 inhibitors, and insulin, including joint pilots with providers and payers and the generation of real-world evidence.

We are looking for partners interested in integrated care solutions and improving outcomes through a combination of therapy and behaviour.

Similar opportunities